Inventor
BALOG JAMES AARON
US57 patents
⚠️ This page may combine multiple inventors who share the name “BALOG JAMES AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
41 patentsUS7141578B2Nov 28, 2006
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO17 citations92
US9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US7001911B2Feb 21, 2006
Fused cyclic modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO31 citations91
US11066383B2Jul 20, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations73
US10696648B2Jun 30, 2020
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations73
US10689331B2Jun 23, 2020
IDO inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US10633342B2Apr 28, 2020
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO2 citations73
US9895330B2Feb 20, 2018
IDO inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US9675571B2Jun 13, 2017
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
BRISTOL MYERS SQUIBB CO6 citations73
US9624188B2Apr 18, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US7087636B2Aug 8, 2006
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO9 citations73
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US10399933B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations72
US9758492B2Sep 12, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO4 citations72
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US9765018B2Sep 19, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO4 citations71
US8969586B2Mar 3, 2015
Substituted bicyclic heteroaryl compounds
BRISTOL MYERS SQUIBB CO2 citations63
US7776859B2Aug 17, 2010
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
BRISTOL MYERS SQUIBB CO2 citations63
US7235563B2Jun 26, 2007
Spirocyclic compounds useful as modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO3 citations63
US11649212B2May 16, 2023
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US11351164B2Jun 7, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US11337970B2May 24, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US10544099B2Jan 28, 2020
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations62
US9133139B2Sep 15, 2015
Fluoroalkyl-1,4-benzodiazepinone compounds
BRISTOL MYERS SQUIBB CO2 citations62
US7550458B2Jun 23, 2009
Tricycloundecane compounds useful as modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO2 citations62
US7517904B2Apr 14, 2009
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO1 citations62
US12145927B2Nov 19, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11548870B2Jan 10, 2023
Compounds useful as inhibitors of helios protein
BRISTOL MYERS SQUIBB CO1 citations61
US11447449B2Sep 20, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US7432267B2Oct 7, 2008
Fused cyclic modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO2 citations61
US7655688B2Feb 2, 2010
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO5 citations60
US12331045B2Jun 17, 2025
Substituted phenyl oxazolone compounds
BRISTOL MYERS SQUIBB CO0 citations58
US11718601B2Aug 8, 2023
Pyridinyl substituted oxoisoindoline compounds
BRISTOL MYERS SQUIBB CO0 citations56
US12291522B2May 6, 2025
Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US11066392B2Jul 20, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations52
US9598436B2Mar 21, 2017
Substituted bicyclic heteroaryl compounds
BRISTOL MYERS SQUIBB CO0 citations52
US7342034B2Mar 11, 2008
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO0 citations52
US12059420B2Aug 13, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations51
US7655689B2Feb 2, 2010
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO1 citations51
FLEXUS BIOSCIENCES INC
7 patentsUS9598422B2Mar 21, 2017
Immunoregulatory agents
FLEXUS BIOSCIENCES INC21 citations93
US9643972B2May 9, 2017
Immunoregulatory agents
FLEXUS BIOSCIENCES INC15 citations91
US10106546B2Oct 23, 2018
Immunoregulatory agents
FLEXUS BIOSCIENCES INC6 citations83
US10533014B2Jan 14, 2020
Immunoregulatory agents
FLEXUS BIOSCIENCES INC3 citations72
US11932601B2Mar 19, 2024
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations61
US11242319B2Feb 8, 2022
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations61
US10206893B2Feb 19, 2019
Immunoregulatory agents
FLEXUS BIOSCIENCES INC0 citations51
VELAPARTHI UPENDER
1 patentAUSTIN JOEL FRANCIS
1 patentShowing the top 50 of 57 patents by PatentIndex Score.